China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.64
+0.31 (5.82%)
At close: Mar 27, 2026

HKG:3320 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
15,84416,42524,65115,22414,267
Short-Term Investments
-9,2237,5817,5079,766
Cash & Short-Term Investments
15,84425,64832,23122,73124,034
Cash Growth
-38.22%-20.43%41.79%-5.42%57.29%
Accounts Receivable
92,468101,67095,69584,81878,175
Other Receivables
9,1938,6576,9126,8457,612
Receivables
101,661110,327102,60791,66385,787
Inventory
43,27137,05331,87526,54724,186
Prepaid Expenses
4,0064,0764,7974,9533,506
Restricted Cash
----10.39
Other Current Assets
36,9258,7427,0576,3666,356
Total Current Assets
201,707185,846178,568152,259143,879
Property, Plant & Equipment
32,41125,90725,04321,69820,398
Long-Term Investments
7,1866,1436,8786,6226,388
Goodwill
24,34222,36921,45420,40920,287
Other Intangible Assets
11,2036,9486,5366,3596,149
Long-Term Deferred Tax Assets
2,3751,9691,7731,4351,067
Long-Term Deferred Charges
-1,5601,4811,2061,184
Other Long-Term Assets
6,5887,0185,0375,5463,146
Total Assets
285,811257,760246,770215,534202,497
Accounts Payable
64,57658,78654,45148,85342,673
Accrued Expenses
5,3114,7344,2215,3604,226
Short-Term Debt
---10,16710,018
Current Portion of Long-Term Debt
49,83644,85345,76035,94138,259
Current Portion of Leases
492.94520.27463.53495.95475.61
Current Income Taxes Payable
917.9954.9730.03667.3728.63
Current Unearned Revenue
4,1424,2254,0233,5382,898
Other Current Liabilities
16,93418,14924,58516,74715,854
Total Current Liabilities
142,209132,222134,233121,770115,132
Long-Term Debt
21,34722,86415,0929,0425,850
Long-Term Leases
730.03768.14844.89770.27759.16
Long-Term Unearned Revenue
-713.72788.58775.14725.69
Pension & Post-Retirement Benefits
744.51773.54761.7828.95886.72
Long-Term Deferred Tax Liabilities
2,1311,9151,7181,5871,601
Other Long-Term Liabilities
1,194416.48356.96203.29161.17
Total Liabilities
168,355159,673153,795134,977125,116
Common Stock
24,63024,63024,63024,63022,193
Retained Earnings
-31,56729,70526,73123,134
Comprehensive Income & Other
26,778-7,953-8,376-7,804-3,794
Total Common Equity
51,40848,24445,96043,55741,533
Minority Interest
66,04749,84347,01537,00035,848
Shareholders' Equity
117,45698,08792,97580,55777,381
Total Liabilities & Equity
285,811257,760246,770215,534202,497
Total Debt
72,40669,00562,16156,41655,362
Net Cash (Debt)
-56,562-43,357-29,930-33,685-31,328
Net Cash Per Share
-9.00-6.90-4.76-5.36-4.99
Filing Date Shares Outstanding
6,2836,2836,2836,2836,283
Total Common Shares Outstanding
6,2836,2836,2836,2836,283
Working Capital
59,49853,62444,33530,48928,747
Book Value Per Share
8.187.687.326.936.61
Tangible Book Value
15,86418,92817,96916,78915,098
Tangible Book Value Per Share
2.533.012.862.672.40
Buildings
-17,26416,12413,50712,991
Machinery
-13,55712,51110,5569,366
Construction In Progress
-1,5051,3391,930972.25
Leasehold Improvements
-1,059960.31741.77660.19
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.